EMR:NYSEEmerson Electric Company Analysis

Emerson Electric (EMR) trades at a **price of $128.14**, which sits well above its **DCF fair value of $59.09** and carries a **trailing P/E of 31.4**, higher than the industry average of 28.3, suggesting the stock is currently overvalued. Technical gauges show a **neutral trend** with the price below the 20‑day SMA (132.9) and 50‑day SMA (143.5), a **bearish MACD** histogram, and an RSI of 38 that hints at modest oversold pressure but not a clear reversal signal. The stock is near its **support level of $122.64**, while the next resistance sits at $148.30, framing a relatively tight price corridor. On the fundamentals side, EMR posted **4.1% revenue growth**, a solid **operating margin of 24.6%**, and **free cash flow of $2.88 B**, underpinning a **dividend yield of 1.8%** with a **payout ratio of 52%**, indicating dividend sustainability. Analyst sentiment remains positive with a **median 12‑month price target of $168** and a “buy” recommendation, reflecting confidence in earnings momentum and cash generation. However, the **beta of 1.29** and **30‑day volatility of 33%** point to heightened market sensitivity, and recent insider sales add a note of caution.
Balancing these factors, EMR appears overvalued in the near term, but its strong cash flow, stable dividend, and growth prospects support a more favorable outlook over the medium to long horizon, provided investors can tolerate the stock’s price volatility and cyclical industrial exposure.